I also posted the following on the Yahoo TGX thread.
(Note: That thread has suddenly turned interesting ... the name calling and yammer has been overtaken with some good postings from Therapyu DR and Physicsguru. If you check messages starting at about # 10720 and read through # 10756 you will see some very interesting postings on IBt and some changes in technology they and others are trying.)
IBt Press release 12/23/99 Msg: 10757 of 10757
Several interesting points: ie:
- they have yet to "obtain the CE Mark required to start the sales in the EU".
- they are being distributed in the US.
- they state 40,000 patients treated in the US in 1999.
- brachy centers in Eu have jumped from 2 in 1998 to 20 in 1999. (Whose seeds are they using? Not IBt's.)
Press releases - 23/12/1999
Ibt : first patients treated in the U.S. with the implants of Ibt
Seneffe, December 22, 1999.
International Brachytherapy sa (IBt on EURO.NM Belgium). The first palladium brachytherapy implants of IBt,
InterSource103, have been successfully used in a number of medical centers in the U.S. to treat patients with localized prostate cancer. These first sales have been
completed by the American subsidiary of IBt, located in Atlanta, Georgia.
On the American market, IBt works in collaboration with BARD, its US distributor and one of the world leaders in medical devices for urology applications.
For the European distribution, IBt has already started the procedure to obtain the CE Mark required to start the sales in the EU. IBt anticipates to obtain this authorization in
the first part of the year 2000.
IBt Inc. has recently opened its web site, www.ibt4seeds.com.
The use of the brachytherapy technique for the treatment of localized prostate cancer continues to grow. In the U.S., where brachytherapy has been practiced for over 10
years, more than 40.000 patients with localized prostate cancer have been treated with brachytherapy in 1999. In Europe, new brachytherapy centers appear every year.
While only two centers were offering the brachytherapy treatment in early 1998 (in Leeds and Utrecht), there are today more than 20 centers in France, Belgium, Italy,
Austria, Greece, Germany, U.K. and in The Netherlands. International Brachytherapy SA, a Belgian start-up company listed on the EURO.NM, has as its mission to
develop, manufacture and market on a worldwide basis a complete range of radiotherapeutic implants used in brachytherapy. Brachytherapy is a minimally invasive medical
procedure which involves placing implants that contain a small quantity of a radioactive isotope inside the tumor. The precisely positioned implants act to destroy the
cancerous cells. The main application of
the brachytherapy today is the treatment of localized prostate cancer.
Contacts: 064/520 811
Francois Blondel, CFO
Serge Lamisse, VP Sales & Marketing |
